Modulation of GSH levels in ABCC1 expressing tumor cells triggers apoptosis through oxidative stress

Biochemical Pharmacology

Volumn 73, Issue 11, 2007, Pages 1727-1737

  Laberge, Rémi Martin ^a   Karwatsky, Joel ^a   Lincoln, Maximilian C ^a   Leimanis, Mara L ^a   Georges, Elias ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Apigenin; ATP binding cassette; Glutathione; l Buthionine (S,R) sulfoximine; Multidrug resistance; Reactive oxygen species

Indexed keywords

ABC TRANSPORTER A1; APIGENIN; BUTHIONINE SULFOXIMINE; GLUTATHIONE; VERAPAMIL;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; FEMALE; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; IC 50; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TUMOR CELL;

APOPTOSIS; CELL LINE, TUMOR; GLUTATHIONE; HELA CELLS; HUMANS; LUNG NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OXIDATIVE STRESS;

EID: 34247149458     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.02.005     Document Type: Article

References (51)

1. Polgar O., and Bates S.E. ABC transporters in the balance: is there a role in multidrug resistance?. Biochem Soc Trans 33 (2005) 241-245
2. Leonard G.D., Fojo T., and Bates S.E. The role of ABC transporters in clinical practice. Oncologist 8 (2003) 411-424
3. Baas F., Jongsma A.P., Broxterman H.J., Arceci R.J., Housman D., Scheffer G.L., et al. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res 50 (1990) 5392-5398
4. Mirski S.E., Gerlach J.H., and Cole S.P. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res 47 (1987) 2594-2598
5. McGrath T., and Center M.S. Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein. Biochem Biophys Res Commun 145 (1987) 1171-1176
6. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258 (1992) 1650-1654
7. Flens M.J., Zaman G.J., van der Valk P., Izquierdo M.A., Schroeijers A.B., Scheffer G.L., et al. Tissue distribution of the multidrug resistance protein. Am J Pathol 148 (1996) 1237-1247
8. Gao M., Yamazaki M., Loe D.W., Westlake C.J., Grant C.E., Cole S.P., et al. Multidrug resistance protein. Identification of regions required for active transport of leukotriene C4. J Biol Chem 273 (1998) 10733-10740
9. Cole S.P., Sparks K.E., Fraser K., Loe D.W., Grant C.E., Wilson G.M., et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54 (1994) 5902-5910
10. Hooijberg J.H., Broxterman H.J., Scheffer G.L., Vrasdonk C., Heijn M., de Jong M.C., et al. Potent interaction of flavopiridol with MRP1. Br J Cancer 81 (1999) 269-276
11. Leier I., Jedlitschky G., Buchholz U., Cole S.P., Deeley R.G., and Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269 (1994) 27807-27810
12. Muller M., Meijer C., Zaman G.J., Borst P., Scheper R.J., Mulder N.H., et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91 (1994) 13033-13037
13. Evers R., Zaman G.J., van Deemter L., Jansen H., Calafat J., Oomen L.C., et al. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest 97 (1996) 1211-1218
14. Loe D.W., Almquist K.C., Cole S.P., and Deeley R.G. ATP-dependent 17 beta-estradiol 17-(beta-d-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J Biol Chem 271 (1996) 9683-9689
15. Cole S.P., Downes H.F., Mirski S.E., and Clements D.J. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line. Mol Pharmacol 37 (1990) 192-197
16. Zaman G.J., Lankelma J., van Tellingen O., Beijnen J., Dekker H., Paulusma C., et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92 (1995) 7690-7694
17. Paulusma C.C., van Geer M.A., Evers R., Heijn M., Ottenhoff R., Borst P., et al. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 338 Pt. 2 (1999) 393-401
18. Rappa G., Lorico A., Flavell R.A., and Sartorelli A.C. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 57 (1997) 5232-5237
19. Salerno M., and Garnier-Suillerot A. Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells. Eur J Pharmacol 421 (2001) 1-9
20. Ballatori N., Hammond C.L., Cunningham J.B., Krance S.M., and Marchan R. Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins. Toxicol Appl Pharmacol 204 (2005) 238-255
21. Griffith O.W. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem 257 (1982) 13704-13712
22. Leslie E.M., Deeley R.G., and Cole S.P. Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Drug Metab Dispos 31 (2003) 11-15
23. Cullen K.V., Davey R.A., and Davey M.W. Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells. Biochem Pharmacol 62 (2001) 417-424
24. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1271 (1995) 67-74
25. DeLeve L.D., and Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 52 (1991) 287-305
26. Coppola S., and Ghibelli L. GSH extrusion and the mitochondrial pathway of apoptotic signalling. Biochem Soc Trans 28 (2000) 56-61
27. Merad-Saidoune M., Boitier E., Nicole A., Marsac C., Martinou J.C., Sola B., et al. Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion. Exp Neurol 158 (1999) 428-436
28. Georges E., and Mushynski W.E. Chemical modification of charged amino acid moieties alters the electrophoretic mobilities of neurofilament subunits on SDS/polyacrylamide gels. Eur J Biochem 165 (1987) 281-287
29. Reichlin M. Use of glutaraldehyde as a coupling agent for proteins and peptides. Meth Enzymol 70 (1980) 159-165
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
31. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76 (1979) 4350-4354
32. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65 (1983) 55-63
33. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
34. Karwatsky J., Daoud R., Cai J., Gros P., and Georges E. Binding of a photoaffinity analogue of glutathione to MRP1 (ABCC1) within two cytoplasmic regions (L0 and L1) as well as transmembrane domains 10-11 and 16-17. Biochemistry 42 (2003) 3286-3294
35. Nare B., Prichard R.K., and Georges E. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells. Mol Pharmacol 45 (1994) 1145-1152
36. Georges E., Zhang J.T., and Ling V. Modulation of ATP and drug binding by monoclonal antibodies against P-glycoprotein. J Cell Physiol 148 (1991) 479-484
37. Fairbanks G., Steck T.L., and Wallach D.F. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10 (1971) 2606-2617
38. Kurz E.U., Cole S.P., and Deeley R.G. Identification of DNA-protein interactions in the 5′ flanking and 5′ untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. Biochem Biophys Res Commun 285 (2001) 981-990
39. Trompier D., Chang X.B., Barattin R., du Moulinet D'Hardemare A., Di Pietro A., and Baubichon-Cortay H. Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1. Cancer Res 64 (2004) 4950-4956
40. Lash L.H. Role of glutathione transport processes in kidney function. Toxicol Appl Pharmacol 204 (2005) 329-342
41. Loe D.W., Deeley R.G., and Cole S.P. Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). J Pharmacol Exp Ther 293 (2000) 530-538
42. Leslie E.M., Mao Q., Oleschuk C.J., Deeley R.G., and Cole S.P. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. Mol Pharmacol 59 (2001) 1171-1180
43. Deeley R.G., and Cole S.P. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett 580 (2006) 1103-1111
44. Meister A. New developments in glutathione metabolism and their potential application in therapy. Hepatology 4 (1984) 739-742
45. Meister A., and Anderson M.E. Glutathione. Annu Rev Biochem 52 (1983) 711-760
46. Bailey H.H., Mulcahy R.T., Tutsch K.D., Arzoomanian R.Z., Alberti D., Tombes M.B., et al. Phase I clinical trial of intravenous l-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J Clin Oncol 12 (1994) 194-205
47. Bailey H.H., Ripple G., Tutsch K.D., Arzoomanian R.Z., Alberti D., Feierabend C., et al. Phase I study of continuous-infusion l-S,R-buthionine sulfoximine with intravenous melphalan. J Natl Cancer Inst 89 (1997) 1789-1796
48. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 Pt. 2 (1999) 233-249
49. Lennon S.V., Martin S.J., and Cotter T.G. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 24 (1991) 203-214
50. Brookes P., and Darley-Usmar V.M. Hypothesis: the mitochondrial NO(*) signaling pathway, and the transduction of nitrosative to oxidative cell signals: an alternative function for cytochrome C oxidase. Free Radic Biol Med 32 (2002) 370-374
51. Brookes P.S., Levonen A.L., Shiva S., Sarti P., and Darley-Usmar V.M. Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic Biol Med 33 (2002) 755-764